Skip to content

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01525420
Acronym
TALK
Enrollment
121
Registered
2012-02-03
Start date
2012-03-31
Completion date
2013-03-31
Last updated
2014-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Brief summary

The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT). Implementation outcomes: * end of treatment and 6-month follow-up data retention rates; * intervention implementation quality; * number & length of calls completed. Comparison of each arm's implementation

Interventions

BEHAVIORALAcceptance Therapy (ACT)

ACT

OTHERCognitive Behavioral Therapy (CBT)

CBT

Sponsors

Consumer Wellness Solutions
CollaboratorINDUSTRY
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. aged 18 and older; 2. smokes at least 10 cigarettes daily and has done so for at least the past 12 months; 3. wants to quit smoking in the next 30 days; 4. willing to be randomly assigned to either group; 5. willing and able to speak and read in English; 6. willing and medically eligible to use nicotine replacement therapy (NRT), 7. currently resides in the U.S., and expects to continue for at least 12 months; 8. not participating in other smoking cessation interventions; 9. has regular access to a telephone. 10. has regular access to an email address.

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Stopped Smoking by 6 Month Post Treatment6 months30-Day point prevalence abstinence at 6 months post treatment

Secondary

MeasureTime frameDescription
7-day and 24-hour Point Prevalence Quit Rates6-month7-day and 24-hour point prevalence quit rates

Countries

United States

Participant flow

Participants by arm

ArmCount
Acceptance & Commitment Therapy (ACT)
ACT Acceptance & Commitment Therapy (ACT): This is the experimental arm of the study. This included 5 weekly sessions of ACT therapy via telephone.
59
Cognitive Behavioral Therapy (CBT)
CBT Cognitive Behavioral Therapy (CBT): ACT: This is the control arm of the study. This included 5 weekly sessions of CBT therapy via telephone.
62
Total121

Baseline characteristics

CharacteristicAcceptance & Commitment Therapy (ACT)Cognitive Behavioral Therapy (CBT)Total
Age, Continuous39.6 years
STANDARD_DEVIATION 9.5
38.6 years
STANDARD_DEVIATION 10.2
39.1 years
STANDARD_DEVIATION 9.8
Sex: Female, Male
Female
39 Participants45 Participants84 Participants
Sex: Female, Male
Male
20 Participants17 Participants37 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 590 / 62
serious
Total, serious adverse events
2 / 590 / 62

Outcome results

Primary

Number of Participants Who Stopped Smoking by 6 Month Post Treatment

30-Day point prevalence abstinence at 6 months post treatment

Time frame: 6 months

ArmMeasureValue (NUMBER)
Acceptance & Commitment Therapy (ACT)Number of Participants Who Stopped Smoking by 6 Month Post Treatment18 participants
Cognitive Behavioral Therapy (CBT)Number of Participants Who Stopped Smoking by 6 Month Post Treatment14 participants
Secondary

7-day and 24-hour Point Prevalence Quit Rates

7-day and 24-hour point prevalence quit rates

Time frame: 6-month

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026